PROVIDENCE (AP) -- Rhode Island's General Assembly has approved a measure to prohibit life insurance companies from denying or limiting policies for people with a prescription for an opioid overdose-reversal medication.
The bill heads to the governor's desk, after passing the House on Monday and the Senate last month.
Democratic Senate President Dominick Ruggerio and Democratic Rep. Justine Caldwell, of East Greenwich, sponsored the bill.
The issue came to Ruggerio's attention because a nurse who got a naloxone prescription was denied life insurance in Rhode Island.
The bill says no life insurance company in Rhode Island can deny a policy application solely on the basis that the applicant has a prescription to carry or possess naloxone.
Rhode Island has an "open prescription" for naloxone, meaning anyone can obtain it at a pharmacy.
___
(c)2019 The Providence Journal (Providence, R.I.)
Visit The Providence Journal (Providence, R.I.) at www.projo.com
RIAs Talk The Talk But Don’t Always Walk The Walk On Annuities
AM Best Assigns Credit Ratings to Beazley America Insurance Company, Inc.
Advisor News
- When new investment trends emerge, Gen Z is most likely generation to be first in
- Could ‘plain English’ become an advisor’s secret weapon?
- IRI urges Senate action on 403(b) parity legislation
- Three estate planning ideas to protect your clients and their wealth
- What advisors must know about accessible client documents
More Advisor NewsAnnuity News
- NUNN INTRODUCES BILL TO CUT RED TAPE, GIVE IOWANS CLEARER INSURANCE INFORMATION
- NAIC working group pressed to accelerate annuity illustration overhaul
- State Auditor James Brown Kicks Off Life Insurance Awareness Month With Policy Locator Tool
- Wink: Annuity sales post strong Q2, led by MYGAs and structured products
- Legacy Marketing Group partners with Malibu Life USA for annuity launch
More Annuity NewsHealth/Employee Benefits News
Life Insurance News